Department of Clinical Neuroscience
Umeå, Västerbotten County, SE-901 85, Sweden
NCT Number: NCT01265251
A computerised neuropsychological test battery to be used as a standardised tool assessing the cognitive domains affected by idiopathic normal pressure hydrocephalus INPH was developed. The aim of this study is to investigate the reliability, validity and feasibility of the battery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Umeå, Västerbotten County, SE-901 85, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Computerized neuropsychological test battery.
Conventional neuropsychological test (paper and pen)
Time frame: Within 24 h
Computerized test battery and equivalent standard neuropsychological test battery is given to the same subject. Correlation between paper and pen and equivalent computerized test is calculated as a validity measure.
Time frame: More than 7 days, within 2 months
The computerized test battery is given to the same subject twice. Correlation between the two tests is calculated as a test-retest reliability measure.
Time frame: Within 24 h
Patients under the investigation for INPH are given the computerized test battery. Number of patients who manage to complete the test is the feasibility measure.
Umeå University
Other
Evaluation of a Computerised Neuropsychological Test Battery for Idiopathic Normal Pressure Hydrocephalus (INPH)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01909960
Brain Diseases, Central Nervous System Diseases
Lille, Hauts-de-France, France
View Trial DetailsNCT01815775
Brain Diseases, Central Nervous System Diseases
Amiens, Picardie, France
View Trial DetailsNCT06857136
Brain Diseases, Central Nervous System Diseases
Milan, Italy
View Trial DetailsNCT02016352
Brain Diseases, Central Nervous System Diseases
Toulouse, France
View Trial Details